Martin D. McCarter

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu et al. · The Lancet · 2009 · 1.4K citations · Full text

Medicine, Oncology, Surgery +11

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.2K citations · Full text

Medicine, Oncology, Surgery +17

Pathologic and Molecular Features Correlate With Long-Term Outcome After Adjuvant Therapy of Resected Primary GI Stromal Tumor: The ACOSOG Z9001 Trial

Christopher L. Corless, Karla V. Ballman, Cristina R. Antonescu et al. · Journal of Clinical Oncology · 2014 · 315 citations · Full text

Medicine, Oncology, Molecular Oncology +16

Antigen-Presenting Intratumoral B Cells Affect CD4+ TIL Phenotypes in Non–Small Cell Lung Cancer Patients

Tullia C. Bruno, Peggy J. Ebner, Brandon L. Moore et al. · Cancer Immunology Research · 2017 · 303 citations · Full text

Life Sciences, Immunology, Oncology +17

NCCN Guidelines Insights: Soft Tissue Sarcoma, Version 1.2021

Margaret von Mehren, John M. Kane, Marilyn M. Bui et al. · Journal of the National Comprehensive Cancer Network · 2020 · 303 citations

Medicine, Oncology, Radiation Oncology +16